INSIGHTS

Mass Tort Leads: What Attorneys Need to Know Before Buying (2026 Guide)

Updated November 19, 2026·Legal Leads
Mass Tort Leads: What Attorneys Need to Know Before Buying (2026 Guide)

By Fadi Agour, J.D. · Updated November 19, 2026 · Facts last reviewed November 19, 2026

Short answer: A mass tort lead is a person who reports using a specific product, drug or exposure and suffering a specific injury, and who asks for a lawyer. Unlike a personal injury lead, it is national rather than local, screened against written criteria written for one tort (product, dates of use, diagnosis, filing deadline), and bought in volume because each case is one of thousands consolidated before one judge. As of November 2, 2026, there were 204,987 actions pending in 164 federal MDLs. Firms that do well buy leads or signed retainers against criteria they wrote, track the cost per signed case for each tort, and move quickly when a new MDL forms.

Key takeaways

  • Mass torts are a large share of federal civil litigation. The Judicial Panel on Multidistrict Litigation's November 2, 2026 report lists 164 pending MDLs with 204,987 actions pending; the largest, Johnson & Johnson talcum powder, has 69,376.
  • New torts form every year. In fiscal 2025 the Panel considered 39 motions to centralize and granted 19, and 37,735 civil actions were brought into MDL proceedings.
  • Criteria decide quality. A mass tort lead is only as good as the screening questions it answered: product, use dates, diagnosis, treatment and filing deadline.
  • Intake still decides the outcome. In Clio's secret-shopper study only 40% of firms picked up the phone; a mass tort claimant who does not reach you signs with the next firm.
  • Judge each tort on cost per signed case and expected case value, not cost per lead.

What a mass tort is, and why leads work differently

A mass tort is a civil action involving numerous plaintiffs against one or a few defendants, typically over a defective product, a drug or device, or an environmental exposure. In federal court these claims are usually consolidated through multidistrict litigation under 28 U.S.C. § 1407, a procedure created in 1968 that moves cases sharing common questions of fact to one judge for pretrial proceedings. Each plaintiff keeps an individual claim, which is what separates a mass tort from a class action and what makes each signed claimant valuable to the firm that represents them.

That structure changes everything about the leads. A personal injury firm wants one injured driver in one county. A mass tort firm wants hundreds or thousands of people anywhere in the country who used one product and suffered one injury, found before the filing deadline and before other firms sign them. The leads are generated nationally, screened against tort-specific criteria, and bought at a scale that would make no sense for a car accident practice. Our overview of how mass tort leads are generated covers the mechanics.

The MDL landscape in late 2026

Mass torts are a large and growing share of the federal civil docket. The JPML publishes a monthly count. Its Pending MDL Dockets by Actions Pending report dated November 2, 2026 shows 164 MDL dockets before 142 judges in 50 districts, with 204,987 actions pending and 719,296 actions historically. A year earlier, the November 3, 2025 report showed 157 dockets and 197,981 pending actions. For context, the JPML has reported that MDL cases made up 51.9% of all pending federal civil cases at the end of 2018 (Wikipedia, citing JPML data).

RankMDL (November 2, 2026)CourtActions pending
1Johnson & Johnson Talcum Powder Products (MDL 2738)D.N.J.69,376
2Davol / C.R. Bard Polypropylene Hernia Mesh (MDL 2846)S.D. Ohio23,299
3Aqueous Film-Forming Foams (AFFF) (MDL 2873)D.S.C.15,270
4Hair Relaxer Marketing, Sales Practices and Products (MDL 3060)N.D. Ill.12,743
5Proton-Pump Inhibitor Products (No. II) (MDL 2789)D.N.J.11,404

Source: JPML. Counts change monthly; the Panel posts a new report on the first business day of each month at jpml.uscourts.gov.

The pipeline of new torts is just as important as the big dockets. The Panel's fiscal year 2025 statistical analysis reports that 39 motions to centralize were filed, 19 were granted and 14 denied; 37,735 civil actions were brought into coordinated proceedings during the year, 1,398 by transfer from 66 districts and 36,337 filed directly in transferee courts; and 197,118 actions were pending in 158 MDLs at September 30, 2025. A granted motion creates a new market for leads overnight. Our guide to the hottest mass torts tracks which torts are adding the most new federal cases each month.

How a mass tort lead differs from a personal injury lead

Personal injury leadMass tort lead
GeographyOne state, county or metroNational, with state-specific filing rules
What qualifiesInjury, fault, no lawyer, within statuteNamed product or exposure, dates of use, specific diagnosis, treatment proof, filing deadline, no lawyer
ScreeningFour or five intake questionsA written criteria sheet per tort, often 10 to 20 questions
VolumeA few to a few dozen a monthHundreds to thousands per tort
TimingDays after an accidentMonths or years after exposure; driven by news, label changes and MDL events
DeliveryLead, live callLead, live call, claimant traffic or signed retainer
PricingFixed price per lead by marketCustom quote per tort and campaign
Value driverLiability and damages in one caseVolume of qualified claimants times expected per-claimant value

Two differences matter most. First, criteria: a mass tort claimant who used the product but has the wrong diagnosis, or the right diagnosis outside the eligible window, is not a case, so the screening questions must be written before the first ad runs, and the vendor must ask them exactly. Second, timing: the claimant's injury may be years old, so demand spikes when a label changes, a verdict is reported or an MDL forms, and falls as deadlines pass. The FDA's recall and safety alert listings and the JPML's monthly reports are the two public sources to watch.

The four ways firms buy mass tort claimants

Mass tort firms buy in four forms, and many use more than one for the same tort.

  1. Leads. A screened claimant inquiry delivered the moment it qualifies, with the product, exposure dates, diagnosis and timeline. Your intake team contacts, confirms and signs.
  2. Live calls. A screened claimant connected live to your intake line, so the conversation starts immediately. Invoca's 2025 benchmark across more than 60 million calls found 37% of phone leads convert during the call, which is why live calls are popular for torts where intake capacity is the limit.
  3. Claimant traffic. Targeted visitors sent to your own intake pages, for firms that run their own screening.
  4. Signed retainers. A claimant who met your criteria and signed your retainer and authorizations, delivered as a file. Highest price per unit, lowest intake burden, and the form of purchase where criteria and documentation matter most.

Our mass tort leads page explains how each is priced and delivered.

Writing criteria that produce cases

The criteria sheet is the contract between your firm and your vendor. It should state, for the tort:

  • The product, drug or exposure, including brand names and generics.
  • Eligible dates of use or exposure and the minimum duration.
  • Qualifying diagnoses, with the diagnosis date window and whether medical records are required at intake.
  • Disqualifiers: age limits, pre-existing conditions, prior settlements, current representation.
  • The states you will accept, given statutes of limitations and repose.
  • Delivery fields: what the lead record must contain for your team to open a file.

Vague criteria produce leads that look qualified and are not. Written criteria let you measure a vendor on the share of leads that pass intake, and let the vendor stop paying for traffic that produces claimants you reject. Our guide to how to vet mass tort leads covers the vendor questions, and our Camp Lejeune and hair relaxer guides show what tort-specific criteria look like in practice.

Intake: the step most firms underestimate

Buying mass tort leads at volume exposes every weakness in intake. Clio's 2024 secret-shopper study of 500 law firms found that only 40% picked up the phone, 48% were unreachable by phone even after messages, and 33% answered email. A claimant who has been waiting years for someone to take their injury seriously will not wait days for a callback; they will sign with the next firm that calls. Before scaling a tort, firms should have the staff to contact every lead within minutes, a script built from the criteria sheet, e-signature retainers, and a system that records each lead's source and outcome. Our guides to lead tracking and re-evaluating your intake process cover the setup.

Compliance: advertising, fee rules and consent

Three sets of rules apply to buying mass tort leads. First, ABA Model Rule 7.2 and its state versions: a lawyer may pay the reasonable costs of advertising but may not pay for a recommendation, so a compliant lead program delivers inquiries from people who asked for a lawyer without steering them to a particular firm, and prices leads as a fixed charge rather than a share of fees. Second, consent for outreach: the FTC's Telemarketing Sales Rule requires written permission from the consumer, obtained directly rather than through a third party, before telemarketing to numbers on the Do Not Call Registry, and the FCC's TCPA rules require prior express written consent for telemarketing robocalls and texts. Your vendor should document the consent each claimant gave. Third, your state bar's rules on advertising content and disclaimers, which govern what the ads that generate your leads may say.

What mass tort leads cost

Mass tort pricing is quoted per tort because the cost of reaching and screening a qualified claimant varies enormously between a widely used over-the-counter product and a rare prescription drug injury. Best Case Leads quotes mass tort campaigns individually, as a fixed price, never a percentage of fees or settlement. Whatever the price per lead or per signed retainer, the metric that matters is cost per signed case against the expected value of a claim in that tort. The calculator on our pricing page and our cost per signed case guide show the math.

A checklist before your first campaign

  1. Pick the tort with a clear view of the MDL stage, the filing deadlines and the expected per-claimant value.
  2. Write the criteria sheet and the intake script from it.
  3. Confirm intake capacity: who answers in five minutes, including evenings.
  4. Decide the form of purchase: leads, live calls, traffic or signed retainers.
  5. Agree exclusivity, delivery fields, consent documentation and a return policy for leads that fail criteria.
  6. Start small, run 50 to 100 leads, measure the share that pass intake and the cost per signed case, then scale.

How Best Case Leads fits

Best Case Leads sells exclusive mass tort leads, live calls, claimant traffic and signed retainers to law firms. Every campaign is screened to criteria you set for the tort, such as product, use dates, diagnosis and filing deadline. Claimants find us through Mass Torts Co, our consumer brand for people injured by drugs, products and toxic exposure. Each claimant goes to one firm and is never shared or resold, delivery is real time to email, SMS, your CRM or intake system, and pricing is a fixed price quoted up front per campaign. Request a quote on the mass tort leads page.

FAQ

What is a mass tort lead? A person who reports using a specific product, drug or exposure and suffering a specific injury, has asked for a lawyer, and has answered screening questions written for that tort, such as dates of use, diagnosis and filing deadline.

How many mass tort cases are pending in federal court? The JPML's November 2, 2026 report lists 204,987 actions pending in 164 MDLs. The largest is the Johnson & Johnson talcum powder MDL with 69,376 actions.

How is a mass tort lead different from a personal injury lead? It is national rather than local, screened against a written criteria sheet for one tort rather than four or five general questions, bought in volume, and often delivered as a signed retainer rather than a lead.

What do mass tort leads cost? Pricing is quoted per tort and campaign because the cost of reaching a qualified claimant varies widely. Best Case Leads quotes a fixed price up front, never a share of fees or settlement. Judge the price by cost per signed case.

Can a law firm pay for mass tort leads under the ethics rules? ABA Model Rule 7.2 allows paying the reasonable costs of advertising but not paying for a recommendation. Compliant programs deliver inquiries from people who asked for a lawyer at a fixed charge. Check your state's version of the rule.

What is a signed retainer in mass torts? A claimant who met your criteria and signed your retainer agreement and authorizations, delivered to your firm as a completed file rather than as a lead to contact.

About the author

Fadi Agour, J.D., is the Founder and CEO of FadiLaw Marketing LLC, the Houston-based parent company of Best Case Leads, Real Performance Marketing, Masstortsco, and Redo. His companies have made the Inc. 5000 fastest-growing private companies in America list seven years in a row.

Sources

  1. US Judicial Panel on Multidistrict Litigation: Pending MDL Dockets by Actions Pending, November 2, 2026
  2. US Judicial Panel on Multidistrict Litigation: Pending MDL Dockets by Actions Pending, November 3, 2025
  3. US Judicial Panel on Multidistrict Litigation: Fiscal Year 2025 Statistical Analysis
  4. US Judicial Panel on Multidistrict Litigation: Pending MDLs
  5. Wikipedia: Multidistrict litigation
  6. Wikipedia: Mass tort
  7. US Food and Drug Administration: Recalls, Market Withdrawals and Safety Alerts
  8. Clio: Client intake findings from the Legal Trends Report (2024 secret-shopper study)
  9. Invoca: Cross-Channel and Cross-Industry Buyer Conversion Benchmark Report (June 2025)
  10. American Bar Association: Model Rule 7.2
  11. FTC: Complying with the Telemarketing Sales Rule
  12. FCC: Telemarketing and Robocalls

This article is general information, not legal advice. Best Case Leads is not a law firm.

Check availability in your market.

Exclusivity is limited by geography. Tell us your practice area and state, and we'll confirm what's open.

Request Your MarketCall 1-877-79-LAWLEAD